ANTICORPOS ANTI-PD1 E A SUA UTILIZAÇÃO COMO AGENTES TERAPÊUTICOS E DE DIAGNÓSTICO

• 收藏
• 分享

专利权人:

BEIGENE SWITZERLAND GMBH

发明人:

申请号：

PT13893636

公开号：

PT3044234T

申请日:

2013.09.13

申请国别(地区):

PT

年份:

2020

代理人:

摘要：

Provided are antibodies that specifically bind to Programmed Death-1 (PD1, Pdcd-1, or CD279) and inhibit PD1-mediated cellular signaling and activities in immune cells, antibodies binding to a set of amino acid residues required for its ligand binding, and uses of these antibodies to treat or diagnose cancer, infectious diseases or other pathological disorders modulated by PD1-mediated functions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/